Announcements Trials
Browse Landscape

Status

Terminated 4Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 3Liver Neoplasms 1

Interventions

Blood Specimen Collection 27Surveys and Questionnaires 24Magnetic Resonance Spectroscopy 10Observation 7Flow Cytometry 7Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6exemestane 5Radiotherapy 5Magnetic Resonance Imaging 5Immunoenzyme Techniques 5Biopsy 5Radiation 4Neoadjuvant Therapy 4Mental Status and Dementia Tests 4Genetic Testing 4Gene Expression Profiling 4Electroporation 4Data Collection 4Bevacizumab 4Trastuzumab 3Tomography, X-Ray Computed 3Tomography, Optical Coherence 3Therapeutics 3Surgical Procedures, Operative 3Sunitinib 3Sorafenib 3Registries 3Radiosurgery 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Observational × Electroporation × Clear all
NCT02926040 2020-02-27

IRE Qol

Insel Gruppe AG, University Hospital Bern

Terminated
14 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02952859 2020-02-26

IRE Marg

Insel Gruppe AG, University Hospital Bern

Terminated
26 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03069599 2020-02-26

IRE Immuno

Insel Gruppe AG, University Hospital Bern

Terminated
38 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02787954 2018-10-18

Liver

The University of Texas Health Science Center, Houston

Terminated
10 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡